SCHEMBL7947798

SCHEMBL7947798

Cc1noc(NS(=O)(=O)c2ccccc2-c2ccc(OC(F)F)cc2)c1C

nearest known ligand 0.82

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
EDNRA P25101 8/20 0.72
EDNRB P24530 7/20 0.72

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6770711 0.90 EDNRA (0.73) EDNRAEDNRB
SCHEMBL6766562 0.87 EDNRA (0.78) EDNRAEDNRB
SCHEMBL6777867 0.84 EDNRA (0.86) EDNRAEDNRB
SCHEMBL6151288 0.84 EDNRA (1.00) EDNRAEDNRB
SCHEMBL6767702 0.83 EDNRB (0.73) EDNRAEDNRB
SCHEMBL6772268 0.82 EDNRA (0.78) EDNRAEDNRB
SCHEMBL7954867 0.82 EDNRA (0.71) EDNRAEDNRB
SCHEMBL7956742 0.81 EDNRA (0.77) EDNRAEDNRB
SCHEMBL6771908 0.81 EDNRB (0.72) EDNRAEDNRB
SCHEMBL7947185 0.81 EDNRA (1.00) EDNRAEDNRB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0768305-A1 N-Isoxazolyl-biphenylsulfonamide derivatives, their preparation and their use as endothelin antagonists BRISTOL-MYERS SQUIBB COMPANY (US) 1997-04-16 EP claimed
US-6271248-B1 USED IN TREATING HYPERTENSION, PULMONARY HYPERTENSION, RENAL/ GLOMERULAR/MESANGIAL CELL DISORDERS, ENDOTOXEMIA, ISCHEMIA, TUMOR GROWTH, ATHERSCLEROSIS, RESTENOSIS, SUBARACHNOID HEMORRHAGE, PROSTATIC HYPERTROPHY, CONGESTIVE HEART FAILURE BRISTOL-MYERS SQUIBB COMPANY 2001-08-07 US disclosed
US-6080774-A Substituted biphenylsulfonamide endothelin antagonists BRISTOL-MYERS SQUIBB COMPANY (US) 2000-06-27 US disclosed
EP-0768305-A1 N-Isoxazolyl-biphenylsulfonamide derivatives, their preparation and their use as endothelin antagonists BRISTOL-MYERS SQUIBB COMPANY (US) 1997-04-16 EP disclosed